Kale Pharma Private Limited
About Kale Pharma Private Limited
Data last updated:
Kale Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 March 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24231PN2005PTC020449. Its GSTIN is 27AACCK7741D1ZM (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.46 Lakh. It is led by directors including Harshavardhan Digambar Kale and Mugdha Digambar Kale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kalpesh Apts First Floor1231/1 Sadashiv Peth, Pune, Maharashtra, India – 411030.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.67 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹20.5 Lakh (net margin 4.4%) and EBITDA of ₹32.18 Lakh (EBITDA margin 6.9%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years.
As per MCA filings, the company has open charges of ₹43 Lakh and satisfied charges of ₹5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKalpesh Apts First Floor1231/1 Sadashiv Peth, Pune, Maharashtra, India – 411030
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kale Pharma Private Limited
The main business activity of Kale Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kale Pharma Private Limited FY 2025 filings available
Kale Pharma Private Limited reported revenue of ₹4.67 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Kale Pharma Private Limited
Revenue rose 3% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 11%. EBITDA rose 150% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kale Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹32.18 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹20.5 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kale Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kale Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Kale Pharma Private Limited
Kale Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bis Marck Pharmaceuticals Private Limited | ₹4.68 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Rajkot, Gujarat, India |
| Lakshmi Narsimha Diagnostics & Healthcare Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Batra Businesses Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Jaipur, Rajasthan, India |
| Mint Pharmaceuticals Private Limited | ₹4.67 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Chennai, Tamil Nadu, India |
| Wallet Pharma Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | 83.0% | •••• | Hyderabad, Telangana, India |
| Kale Pharma Private Limited this company | ₹4.67 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Pune, Maharashtra, India |
| Dua Health Care Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Delhi, India |
| Exgen Care Private Limited | ₹4.67 Cr (FY 2024) | •••• | •••• | 71.0% | •••• | Noida, Uttar Pradesh, India |
| Avian Life Sciences Private Limited | ₹4.66 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Hyderabad, Telangana, India |
| Biocyte Organics Private Limited | ₹4.66 Cr (FY 2024) | •••• | •••• | 45.0% | •••• | Kanpur, Uttar Pradesh, India |
| Savesol Healthcare Private Limited | ₹4.66 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Kale Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kale Pharma Private Limited
Kale Pharma Private Limited is audited by P P DAKLE & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P P DAKLE & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kale Pharma Private Limited
Kale Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harshavardhan Digambar Kale | Director | 22 Mar 2005 | 21 Years 6 Months | Current |
| Mugdha Digambar Kale | Director | 22 May 2005 | 21 Years 4 Months | Current |
| Digambar Bhalchandra Kale | Director | 15 Dec 2007 | 18 Years 9 Months | Current |
Ownership and Shareholding of Kale Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kale Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2009 | Syndicate Bank | ₹43 Lakh | Open |
| 03 Mar 2006 | The Cosmos Co-Operative Bank Limited | ₹5 Lakh | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Kale Pharma Private Limited
Employment history and EPFO contributions of people linked to Kale Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kale Pharma Private Limited
Kale Pharma Private Limited has 3 board changes on record since 2005: 3 appointments. The latest: Digambar Bhalchandra Kale was appointed as Director on 15 Dec 2007.
Credit Ratings, Litigation & Regulatory Alerts for Kale Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kale Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kale Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kale Pharma Private Limited
Kale Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCK7741D1ZM | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kale Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kale Pharma Private Limited
Kale Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 March 2005 (21+ years old) and is registered under CIN U24231PN2005PTC020449.
Kale Pharma reported revenue of ₹4.67 Cr for FY 2025 (up 3% YoY).
Kale Pharma has 3 current directors:
- Harshavardhan Digambar Kale - Director
- Mugdha Digambar Kale - Director
- Digambar Bhalchandra Kale - Director
Kale Pharma reported a net profit of ₹20.5 Lakh (net margin 4.4%) and EBITDA of ₹32.18 Lakh (EBITDA margin 6.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kale Pharma is -11% over three years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kale Pharma is 27AACCK7741D1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Kale Pharma is U24231PN2005PTC020449. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kale Pharma was incorporated on 22 March 2005, making it 21+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Kale Pharma by revenue are Bis Marck Pharmaceuticals Private Limited, Lakshmi Narsimha Diagnostics & Healthcare Private Limited, Batra Businesses Private Limited, Mint Pharmaceuticals Private Limited, Wallet Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Digambar Bhalchandra Kale was appointed as Director on 15 Dec 2007. Mugdha Digambar Kale was appointed as Director on 22 May 2005. Harshavardhan Digambar Kale was appointed as Director on 22 Mar 2005.
The registered office of Kale Pharma is at Kalpesh Apts First Floor12311 Sadashiv Peth, Pune, Maharashtra, India – 411030.